Insighta Limited

Insighta aims to revolutionize multi-cancer early detection. Backed by world-class science, robust capital resources of US$100m from Prenetics (NASDAQ: PRE), and led by successful entrepreneur Danny Yeung, Insighta is poised to transform cancer screening. This endeavour not only presents an unpreced... Read more